Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii
Authors:
Open Access
- 30 March 2024
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 22 (1) , 1-13
Abstract
Multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) is a formidable pathogen responsible for severe intracranial infections post-craniotomy, exhibiting a mortality rate as high as 71%. Tigecycline (TGC), a broad-spectrum antibiotic, emerged as a potential therapeutic agent for MDR A. baumannii infections. Nonetheless, its clinical application was hindered by a short in vivo half-life and limited permeability through the blood–brain barrier (BBB). In this study, we prepared a novel core–shell nanoparticle encapsulating water-soluble tigecycline using a blend of mPEG-PLGA and PLGA materials. This nanoparticle, modified with a dual-targeting peptide Aβ11 and Tween 80 (Aβ11/T80@CSs), was specifically designed to enhance the delivery of tigecycline to the brain for treating A. baumannii-induced intracranial infections. Our findings demonstrated that Aβ11/T80@CSs nanocarriers successfully traversed the BBB and effectively delivered TGC into the cerebrospinal fluid (CSF), leading to a significant therapeutic response in a model of MDR A. baumannii intracranial infection. This study offers initial evidence and a platform for the application of brain-targeted nanocarrier delivery systems, showcasing their potential in administering water-soluble anti-infection drugs for intracranial infection treatments, and suggesting promising avenues for clinical translation. Graphical abstractKeywords
All Related Versions
Funding Information
- The National Natural Science Foundation of China (82300113)
- China Postdoctoral Science Foundation (2022M722269)
- Sichuan University Postdoctoral Interdisciplinary Innovation Fund (JCXK2204)
- Post Doctor Research Project, West China Hospital, Sichuan University (2023HXBH015)
- West China Nursing Discipline Development Special Fund Project, Sichuan University (HXHL20007)
- Open Research fund of State Key Laboratory of Drug Delivery and Pharmacokinetics, Tianjin Institute of Pharmaceutical Research (010162002, 010162002)
This publication has 29 references indexed in Scilit:
- Lipid Nanoparticle Delivery System for mRNA Encoding B7H3‐redirected Bispecific Antibody Displays Potent Antitumor Effects on Malignant TumorsAdvanced Science, 2022
- mRNA Vaccines Against SARS‐CoV‐2 Variants Delivered by Lipid Nanoparticles Based on Novel Ionizable LipidsAdvanced Functional Materials, 2022
- Surfactants influence polymer nanoparticle fate within the brainBiomaterials, 2021
- Surface modified silk fibroin nanoparticles for improved delivery of doxorubicin: Development, characterization, in-vitro studiesInternational Journal of Biological Macromolecules, 2020
- Blood-Brain Barrier (BBB) Permeability and Transport Measurement In Vitro and In Vivo2020
- Emerging High‐Level Tigecycline Resistance: Novel Tetracycline Destructases Spread via the Mobile Tet(X)BioEssays, 2020
- Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalenceActa Neurochirurgica, 2016
- Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challengesInternational Journal of Pharmaceutics, 2016
- Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brainDrug Discovery Today, 2015
- Double-Coated Poly (Butylcynanoacrylate) Nanoparticulate Delivery Systems for Brain Targeting of Dalargin Via Oral AdministrationJournal of Pharmaceutical Sciences, 2005